Clofazimine does not lead to significant QT interval prolongation: a multicentre study.
dc.contributor.author | Zweijpfenning, SMH | en_US |
dc.contributor.author | van Groningen, H | en_US |
dc.contributor.author | van Ingen, J | en_US |
dc.contributor.author | Magis-Escurra, C | en_US |
dc.contributor.author | Boeree, MJ | en_US |
dc.contributor.author | Wagner, D | en_US |
dc.contributor.author | Bax, H | en_US |
dc.contributor.author | Andrejak, C | en_US |
dc.contributor.author | Wener, R | en_US |
dc.contributor.author | Rahman, A | en_US |
dc.contributor.author | Kunst, H | en_US |
dc.contributor.author | Lorent, N | en_US |
dc.contributor.author | Brouwer, MA | en_US |
dc.contributor.author | Hoefsloot, W | en_US |
dc.contributor.author | NTM-NET | en_US |
dc.date.accessioned | 2019-02-01T17:58:51Z | |
dc.date.available | 2018-08-22 | en_US |
dc.date.issued | 2018-11 | en_US |
dc.date.submitted | 2018-11-19T20:40:23.243Z | |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/55111 | |
dc.language | eng | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | Eur Respir J | en_US |
dc.title | Clofazimine does not lead to significant QT interval prolongation: a multicentre study. | en_US |
dc.type | Article | |
dc.identifier.doi | 10.1183/13993003.01386-2018 | en_US |
pubs.author-url | https://www.ncbi.nlm.nih.gov/pubmed/30385602 | en_US |
pubs.issue | 5 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published online | en_US |
pubs.volume | 52 | en_US |
dcterms.dateAccepted | 2018-08-22 | en_US |
rioxxterms.funder | Default funder | en_US |
rioxxterms.identifier.project | Default project | en_US |
Files in this item
This item appears in the following Collection(s)
-
Centre for Immunobiology [1121]